Floatz logo

Modafinil

Long COVID

Duke UniversitySmall moleculePhase 2Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
89/ 100

Competitive context

31 Active assets in the Long COVID cohort.

Asset / SponsorPhaseRating
Immulina Tm
University of Mississippi Medical Center
Phase 3BB
MELATONIN
Duke University
Phase 2B
Rapamycin
Icahn School of Medicine at Mount Sinai
Phase 3B
Paxlovid
Kanecia Obie Zimmerman
Phase 2B
RITONAVIR
Kanecia Obie Zimmerman
Phase 2B

View all 31 →

Same molecule, other indications

Modafinil is also rated in:

schizoaffective disorderDormant
BB
Indicative ·
70 / 100
View asset →
schizophreniaDormant
BB
Indicative ·
66 / 100
View asset →
schizophreniform disorderDormant
BB
Indicative ·
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →